Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis

Seth Inzaule, Philippa Easterbrook, Ashley Latona, Nathan P Ford, William Irving, Philippa C Matthews, Marco Vitoria, Chris Duncombe, Amalia Giron, Suzanne McCluskey, Olufunmilayo Lesi, Serge Tchamgoue, Rachel Halford, Danjuma Adda, Emma Thomson, Geoff Dusheiko, Michael R Jordan · 2024

Read Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis by Seth Inzaule, Philippa Easterbrook, Ashley Latona, Nathan P Ford, William Irving, Philippa C Matthews, Marco Vitoria, Chris Duncombe, Amalia Giron, Suzanne McCluskey, Olufunmilayo Lesi, Serge Tchamgoue, Rachel Halford, Danjuma Adda, Emma Thomson, Geoff Dusheiko, Michael R Jordan (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11650865.txt.

Description

Inzaule and a large team wrote a review in twenty twenty-four on drug resistance in hepatitis C treatment failures. Modern direct-acting antivirals cure most hepatitis C in short courses. A small share of patients still fail treatment, though. Resistance-linked virus changes may predate care or emerge during it. The team pool studies of resistance after broad-spectrum regimens. Dozens of studies feed the analysis for first and repeat treatment. Resistance changes appear in about four in five first-treatment failures.

After repeat treatment failure, resistance is near universal in the pooled data. Resistance to one drug class, NS5A inhibitors, drives most cases. The authors call for ongoing resistance surveillance worldwide. Risk factors and care impact need study to guide retreatment practice.

Catalog record

CREATORSeth Inzaule, Philippa Easterbrook, Ashley Latona, Nathan P Ford, William Irving, Philippa C Matthews, Marco Vitoria, Chris Duncombe, Amalia Giron, Suzanne McCluskey, Olufunmilayo Lesi, Serge Tchamgoue, Rachel Halford, Danjuma Adda, Emma Thomson, Geoff Dusheiko, Michael R Jordan
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11650865

Browse the full library · About the Tower of Babel